Buy CAS 521-12-0 Supplier & Factory: Technical Procurement Dossier

Stereoselective 2α-Alkylation

Traditional manufacturing suffered from poor epimeric selectivity at the C-2 carbon, leading to 2β-isomer contamination. Next-generation production integrates organometallic catalysts and enantioselective hydrogenation, driving diastereomeric purity well beyond 99.5% with zero cross-stereoisomer baggage.

ICH Q3D Elemental Scrutiny

Global pharmaceutical purchasers no longer accept standard generic assay reports. The integration of ICP-MS metal tracking ensures zero heavy metal catalyst bleed-through (such as palladium or platinum from deprotection sequences), aligning bulk commercial supplies directly with clinical research baselines.

Solvent Closed-Loop Recovery

Driven by dual-carbon mandates and sustainable manufacturing objectives, modern factory processes eliminate toxic chlorinated solvents during 17β-esterification, transitioning to super-critical extraction and high-recovery cyclic ethyl acetate/heptane crystallization systems that diminish environmental footprint.

1. Reference Material & Forensic Standard Calibration

As international testing facilities and reference laboratories (including WADA-accredited and forensic toxicological testing centers) advance high-resolution tandem mass spectrometry (LC-MS/MS and GC-HRMS), the necessity for reference standards with certified traceability and unambiguous isotope profiles is paramount. Drostanolone Propionate (CAS 521-12-0) manufactured under our strict protocol acts as an ultra-pure calibration baseline for urinary metabolite detection, pharmacokinetic quantification curves, and retention time identification.

Each reference sample is packaged under inert argon blanket conditions in light-impervious, amber borosilicate glass ampoules to preserve the integrity of the propionate ester against ambient atmospheric moisture hydrolysis over multi-year storage cycles.

2. Endocrinology & Androgen Receptor Binding Assays

In biomedical academic research and contract research organizations (CROs), Drostanolone represents a unique molecular template: a non-aromatizing androgen exhibiting high selectivity for the androgen receptor (AR) without conversion into estrogens via cytochrome P450 aromatase enzymes. Furthermore, its unique 2α-methyl substitution offers specific metabolic resistance against 3α-hydroxysteroid dehydrogenase inactivation.

Laboratories investigating muscle catabolism models, oncology cell-line responses, and selective androgenic/anabolic dissociation ratios utilize our material to ensure assay outcomes are uncorrupted by trace unreacted androstane intermediates or stereochemical outliers.

3. Synthesis Intermediates for Custom Chemical Modifications

Contract manufacturing facilities utilize bulk CAS 521-12-0 as a high-grade precursor for transesterification, de-esterification to pure drostanolone base (CAS 58-18-4), or further semi-synthetic steroid architecture exploration. The predictable purity curve of our material guarantees that downstream reaction kinetics remain uninhibited by residual carboxylic acids, heavy metal poisoning, or acidic catalyst residues.

4. Stability & Excipient Compatibility Research

Formulation scientists evaluate our high-purity crystalline solid within diverse lipid carrier matrices (such as medium-chain triglycerides, ethyl oleate, and benzyl benzoate co-solvent systems) to document solubility isotherms, crystal polymorphism, and thermodynamic long-term stability under accelerated aging protocols (ICH Q1A guidelines).